Ovarian cancer: A report from population-based cancer registry at central rural India

J Cancer Res Ther. 2023 Jan 1;19(Suppl 2):S857-S862. doi: 10.4103/jcrt.jcrt_1426_22. Epub 2023 Apr 29.

Abstract

Introduction: Ovarian neoplasms affect a huge part of the female population and, simultaneously, have the worst prognosis among all gynecological malignancies. In most of the population-based cancer registries (PBCR) in India, ovarian cancer is the third leading site of cancer among women, trailing behind cervix and breast cancer.

Materials and methods: In the present study, we have summarized the number of new cases of ovarian malignancy and its profile observed in the PBCR in central India during 7 years.

Reports: During a 7-year duration (2010-2016), 6,515 cancer patients were recorded at PBCR, and 228 cases were of ovarian malignancy. It was observed that most of the cases in this study were in 41-50 years of life. The age-standardized incidence rate of ovarian cancers in the present study was 4.61 per 100,000, and the crude incidence rate was 5.08 per 100,000. The crude mortality rate and age-standardized mortality rate of ovarian cancer were 2.3 and 2.02 per 100,000, respectively. Serous carcinoma was our study's most common histological subtype (43.75%), followed by mucinous carcinoma.

Conclusion: A steady increase has been observed in the incidence of ovarian cancer in several registries. A significant goal in managing ovarian cancer is to develop an effective test to detect the disease at its earlier stages, resulting in reduced mortality.

MeSH terms

  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Incidence
  • India / epidemiology
  • Ovarian Neoplasms* / epidemiology
  • Ovarian Neoplasms* / pathology
  • Prognosis
  • Registries